RALEIGH, N.C.--(BUSINESS WIRE)--May 24, 2006--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP - News) today announced results of one investigator-initiated trial of XIFAXAN® (rifaximin) tablets 200 mg presented today at Digestive Disease Week® 2006.
RALEIGH, N.C.--(BUSINESS WIRE)--May 24, 2006--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP - News) today announced results of one investigator-initiated trial of XIFAXAN® (rifaximin) tablets 200 mg presented today at Digestive Disease Week® 2006.
